We are live on ! Find out more
John Overdeck

John Overdeck Two Sigma Investments

AUM $142B Turnover 29.79%
1-Year Est. Return 28.66%
 

John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.

This Fund
S&P 500
This Quarter Est. Return
+3.24%
1 Year Est. Return
+28.66%
3 Year Est. Return
+132.23%
5 Year Est. Return
+130.79%
10 Year Est. Return
+609.97%
AUM
$23.3B
AUM Growth
+$2.3B
Cap. Flow
+$1.28B
Cap. Flow %
5.5%
Top 10 Hldgs %
7.42%
Holding
3,523
New
779
Increased
1,113
Reduced
952
Closed
661
Avg Time Held Equity + Options
0.7 years
Top 10 Avg Time Held Equity + Options
0.3 years
Top 20 Avg Time Held Equity + Options
0.2 years
Avg Time Held Equity only
0.9 years
Top 10 Avg Time Held Equity only
0.3 years
Top 20 Avg Time Held Equity only
0.2 years

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$175M
2
KR icon
Kroger
KR
+$148M
3
ELV icon
Elevance Health
ELV
+$122M
4
EA icon
Electronic Arts
EA
+$120M
5
ABT icon
Abbott
ABT
+$119M

Top Sells

Rank Stock Value
1
TWC
Time Warner Cable
TWC
+$181M
2
HAL icon
Halliburton
HAL
+$152M
3
PFE icon
Pfizer
PFE
+$145M
4
AGN
Allergan plc
AGN
+$124M
5
AZO icon
AutoZone
AZO
+$113M

Sector Composition

Rank Sector Weight
1 Healthcare 13.33%
2 Technology 13.06%
3 Miscellaneous 12.62%
4 Consumer Discretionary 10.5%
5 Financials 9.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ALXN
51
DELISTED
Alexion Pharmaceuticals
ALXN
$91.8M 0.39%
786,516
+607,547
+339% +$86.2M
2016 Q1
1 quarter
REGN icon
52
Regeneron Pharmaceuticals
REGN
$98B
$91.1M 0.39%
260,963
+1,170
+0.5% +$451K
2015 Q3
3 quarters
SBAC icon
53
SBA Communications
SBAC
$18.3B
$90.5M 0.39%
838,206
+113,841
+16% +$11.5M
2013 Q2
12 quarters
QQQ icon
54
Invesco QQQ Trust
QQQ
$454B
$89.5M 0.38%
832,156
+13,454
+2% +$1.45M
2016 Q1
1 quarter
GLPI icon
55
Gaming and Leisure Properties
GLPI
$11.2B
$87.8M 0.38%
2,547,777
+2,018,936
+382% +$66.9M
2015 Q4
2 quarters
GSK icon
56
GSK
GSK
$97.9B
$84.7M 0.36%
1,564,156
+145,742
+10% +$7.68M
2013 Q2
12 quarters
STJ
57
DELISTED
St. Jude Medical
STJ
$81.9M 0.35%
1,049,812
-40,403
-4% -$2.88M
2014 Q1
9 quarters
TYC
58
DELISTED
Tyco International
TYC
$81.5M 0.35%
1,826,902
+650,934
+55% +$27.3M
2015 Q2
4 quarters
RY icon
59
Royal Bank of Canada
RY
$265B
$81.3M 0.35%
1,381,750
+124,152
+10% +$7.46M
2014 Q2
8 quarters
CL icon
60
Colgate-Palmolive
CL
$78.9B
$81.3M 0.35%
1,110,159
-181,543
-14% -$12.9M
2015 Q1
5 quarters
EW icon
61
Edwards Lifesciences
EW
$60.5B
$79.5M 0.34%
2,391,456
+1,810,809
+312% +$62M
2015 Q4
2 quarters
USB icon
62
US Bancorp
USB
$91.5B
$78.4M 0.34%
1,943,247
+1,442,027
+288% +$60M
2014 Q2
8 quarters
YHOO
63
DELISTED
Yahoo
YHOO
$77.3M 0.33%
2,059,113
+1,563,913
+316% +$57.7M
2014 Q1
9 quarters
CVS icon
64
CVS Health
CVS
$106B
$75.8M 0.33%
791,475
+756,489
+2,162% +$75.4M
2015 Q1
5 quarters
AKAM icon
65
Akamai
AKAM
$13.4B
$75.3M 0.32%
1,345,789
-494,154
-27% -$26M
2014 Q3
7 quarters
TD icon
66
Toronto Dominion Bank
TD
$191B
$75M 0.32%
1,753,095
+918,300
+110% +$40M
2014 Q2
8 quarters
SJM icon
67
J.M. Smucker
SJM
$14.4B
$74.3M 0.32%
487,617
+300,317
+160% +$39.9M
2015 Q1
5 quarters
MFC icon
68
Manulife Financial
MFC
$71.4B
$74.1M 0.32%
5,434,046
+1,010,337
+23% +$14.4M
2014 Q2
8 quarters
EXPE icon
69
Expedia Group
EXPE
$29.7B
$72.2M 0.31%
679,084
-393,901
-37% -$42.8M
2014 Q4
6 quarters
ETN icon
70
Eaton
ETN
$133B
$67.7M 0.29%
1,133,703
-746,115
-40% -$45.8M
2014 Q3
7 quarters
FE icon
71
FirstEnergy
FE
$27.7B
$66.7M 0.29%
1,910,981
+494,470
+35% +$16.8M
2015 Q4
2 quarters
GXP
72
DELISTED
Great Plains Energy
GXP
$66.6M 0.29%
+2,191,602
New +$67.3M
2016 Q2
0 quarters
WCN icon
73
Waste Connections
WCN
$45.7B
$65.9M 0.28%
1,373,280
+836,325
+156% +$38.1M
2016 Q1
1 quarter
PPG icon
74
PPG Industries
PPG
$27.3B
$65.8M 0.28%
631,455
+19,703
+3% +$2.15M
2015 Q3
3 quarters
JAZZ icon
75
Jazz Pharmaceuticals
JAZZ
$15.9B
$65.2M 0.28%
461,377
+398,023
+628% +$58.7M
2015 Q3
3 quarters

Similar funds

John Overdeck's Q2 2016 Portfolio in Review

As of Q2 2016, John Overdeck held 3,523 positions worth $23.3B, up 11% from $21B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.

John Overdeck deployed $1.28B of net new capital in Q2 2016, opening 779 new positions and adding to 1,113 existing holdings. Its largest new stake was Kroger: 4,100,027 shares worth $151M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 13% a quarter earlier, followed by Technology and Miscellaneous.

On the sell side, the largest reduction was Pfizer, an estimated $145M trimmed.

  • John Overdeck's largest Q2 2016 buy was Kroger: 4,100,027 shares worth $151M.
  • John Overdeck added most to Nike in Q2 2016, an estimated $175M increase.
  • John Overdeck's biggest Q2 2016 reduction was Pfizer, cutting an estimated $145M.
  • John Overdeck fully exited Time Warner Cable in Q2 2016, selling an estimated $181M.
  • John Overdeck's ten largest holdings make up 7.4% of its $23.3B portfolio in Q2 2016.
  • John Overdeck opened 779 new positions and closed 661 in Q2 2016.
  • John Overdeck's portfolio value rose 11% quarter-over-quarter to $23.3B.

Based on Two Sigma Investments's 13F filing for Q2 2016, filed 15 Aug 2016.